Acceptability and feasibility of plasma phosphorylated‐tau181 in two memory services
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Geriatric Psychiatry"
DOI: 10.1002/gps.5897
Abstract: Plasma phosphorylated‐tau181 (p‐tau181) represents a novel blood‐based biomarker of Alzheimer's disease pathology. We explored clinicians' experience of the utility of plasma p‐tau181 in Camden and Islington Memory Services. read more here.
Keywords: acceptability feasibility; phosphorylated tau181; memory services; plasma ... See more keywords
Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease
Sign Up to like & getrecommendations! Published in 2022 at "Neurology"
DOI: 10.1212/wnl.0000000000201517
Abstract: Background and Objectives Plasma phosphorylated tau at threonine 181 (p-tau181), a well-validated marker of Alzheimer disease (AD) pathologic change, could be a more efficient way to diagnose AD than invasive or expensive biomarkers requiring CSF… read more here.
Keywords: disease; alzheimer disease; mbi; alzheimer ... See more keywords